GeneFerm Biotechnology (Taiwan) Market Value
| 1796 Stock | TWD 49.95 0.45 0.89% |
| Symbol | GeneFerm |
GeneFerm Biotechnology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to GeneFerm Biotechnology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of GeneFerm Biotechnology.
| 10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in GeneFerm Biotechnology on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding GeneFerm Biotechnology Co or generate 0.0% return on investment in GeneFerm Biotechnology over 30 days. GeneFerm Biotechnology is related to or competes with Taiwan Steel, WinMate Communication, China Steel, Shinkong Insurance, Sunny Friend, Chief Telecom, and Ching Feng. GeneFerm Biotechnology Co., Ltd. develops, manufactures, markets, and sells fermented products in Taiwan and internation... More
GeneFerm Biotechnology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure GeneFerm Biotechnology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess GeneFerm Biotechnology Co upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.65 | |||
| Information Ratio | 0.0079 | |||
| Maximum Drawdown | 10.82 | |||
| Value At Risk | (2.50) | |||
| Potential Upside | 3.65 |
GeneFerm Biotechnology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for GeneFerm Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as GeneFerm Biotechnology's standard deviation. In reality, there are many statistical measures that can use GeneFerm Biotechnology historical prices to predict the future GeneFerm Biotechnology's volatility.| Risk Adjusted Performance | 0.0641 | |||
| Jensen Alpha | 0.1549 | |||
| Total Risk Alpha | (0.15) | |||
| Sortino Ratio | 0.0088 | |||
| Treynor Ratio | (0.60) |
GeneFerm Biotechnology Backtested Returns
At this stage we consider GeneFerm Stock to be very steady. GeneFerm Biotechnology holds Efficiency (Sharpe) Ratio of 0.0267, which attests that the entity had a 0.0267% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for GeneFerm Biotechnology, which you can use to evaluate the volatility of the firm. Please check out GeneFerm Biotechnology's Risk Adjusted Performance of 0.0641, market risk adjusted performance of (0.59), and Downside Deviation of 1.65 to validate if the risk estimate we provide is consistent with the expected return of 0.0479%. GeneFerm Biotechnology has a performance score of 2 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of -0.22, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning GeneFerm Biotechnology are expected to decrease at a much lower rate. During the bear market, GeneFerm Biotechnology is likely to outperform the market. GeneFerm Biotechnology right now retains a risk of 1.79%. Please check out GeneFerm Biotechnology coefficient of variation, jensen alpha, and the relationship between the downside deviation and standard deviation , to decide if GeneFerm Biotechnology will be following its current trending patterns.
Auto-correlation | -0.25 |
Weak reverse predictability
GeneFerm Biotechnology Co has weak reverse predictability. Overlapping area represents the amount of predictability between GeneFerm Biotechnology time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of GeneFerm Biotechnology price movement. The serial correlation of -0.25 indicates that over 25.0% of current GeneFerm Biotechnology price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.25 | |
| Spearman Rank Test | -0.52 | |
| Residual Average | 0.0 | |
| Price Variance | 0.72 |
GeneFerm Biotechnology lagged returns against current returns
Autocorrelation, which is GeneFerm Biotechnology stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting GeneFerm Biotechnology's stock expected returns. We can calculate the autocorrelation of GeneFerm Biotechnology returns to help us make a trade decision. For example, suppose you find that GeneFerm Biotechnology has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
GeneFerm Biotechnology regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If GeneFerm Biotechnology stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if GeneFerm Biotechnology stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in GeneFerm Biotechnology stock over time.
Current vs Lagged Prices |
| Timeline |
GeneFerm Biotechnology Lagged Returns
When evaluating GeneFerm Biotechnology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of GeneFerm Biotechnology stock have on its future price. GeneFerm Biotechnology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, GeneFerm Biotechnology autocorrelation shows the relationship between GeneFerm Biotechnology stock current value and its past values and can show if there is a momentum factor associated with investing in GeneFerm Biotechnology Co.
Regressed Prices |
| Timeline |
Pair Trading with GeneFerm Biotechnology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if GeneFerm Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneFerm Biotechnology will appreciate offsetting losses from the drop in the long position's value.Moving against GeneFerm Stock
| 0.55 | 6620 | Handa Pharmaceuticals | PairCorr |
| 0.45 | 4114 | Synmosa Biopharma | PairCorr |
| 0.34 | 6785 | Alar Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to GeneFerm Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GeneFerm Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GeneFerm Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GeneFerm Biotechnology Co to buy it.
The correlation of GeneFerm Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as GeneFerm Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if GeneFerm Biotechnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for GeneFerm Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for GeneFerm Stock Analysis
When running GeneFerm Biotechnology's price analysis, check to measure GeneFerm Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneFerm Biotechnology is operating at the current time. Most of GeneFerm Biotechnology's value examination focuses on studying past and present price action to predict the probability of GeneFerm Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneFerm Biotechnology's price. Additionally, you may evaluate how the addition of GeneFerm Biotechnology to your portfolios can decrease your overall portfolio volatility.